AI and RNA-sequencing blood screening tests for disease detection.
| Date | Round | Amount |
|---|---|---|
| Mar 2023 | Seed London biotech MultiplAI Health raised a $2.7M seed led by Zentynel, SF500 and Time Partners for its AI blood-screening test. | $2.7M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.